search
NASDAQ:TRVI
USD
6.6
- (-0.9%)
TREVI THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
USD 6.600
- (-0.9%)
End of Day: 8 May 2025 GMT-4
Industry: Biotechnology

Quote

Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-

Company Info

more

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of c...

Key Ratios

more

Income

more

Balance Sheet

more

Cash Flow

more

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices